Leidos Appoints AT&T COO Jeff McElfresh to Board of Directors
Leidos Holdings, Inc. announced on October 1, 2026, that it has appointed Jeffery S. McElfresh to its Board of Directors, effective immediately. Mr. McElfresh joins the company fro…
Full-length, AI-written pieces grounded in real filings and disclosures — factual filing digests and thesis-derived research analysis, distinct from the real-time wire feed.
Leidos Holdings, Inc. announced on October 1, 2026, that it has appointed Jeffery S. McElfresh to its Board of Directors, effective immediately. Mr. McElfresh joins the company fro…
Alaska Silver Corp. has announced a leadership transition effective October 1, 2026. Aaron Schutt, who was appointed to the company's board of directors in May 2026, will succeed C…
Boeing Company (NYSE: BA) announced several new agreements this week, including a multi-billion-dollar contract with the U.S. Navy and an order from Ethiopian Airlines. On Monday, …
Keurig Dr Pepper Inc. (KDP) announced on October 1, 2026, that its Board of Directors has appointed Russ Torres as the Chief Executive Officer of the company’s Coffee Operating Uni…
On October 1, 2026, Slam Corp. issued an Amended and Restated Consolidated Promissory Note to Slam Sponsor, LLC. The new note amends, restates, and consolidates ten promissory note…
Acuity Inc. (NYSE: AYI) reported its financial results for the fiscal quarter and year ended August 31, 2026, in a press release filed with the SEC on October 1, 2026. The company …
Kyntra Bio, Inc. (Nasdaq: KYNB) announced several changes to its leadership structure in a filing dated September 30, 2026. The company has appointed Andrew E. Singer, MBA, as a Cl…
Chesapeake Utilities Corporation has entered into an Equity Distribution Agreement to sell up to $225 million of its common stock through an at-the-market (ATM) program. The agreem…
McCormick & Company, Incorporated reported financial results for the third quarter of fiscal year 2026, which ended August 31, 2026. The company reported total net sales of $2,024 …
Installed Building Products, Inc. (NYSE: IBP) announced on October 1, 2026, the release of its 2026 Environmental, Social and Governance (ESG) report. The filing details the compan…
Monte Rosa Therapeutics, Inc. (Nasdaq: GLUE) announced positive data from the GFORCE-1 Phase 1 study of MRT-8102, a molecular glue degrader targeting the NEK7 protein. The study ev…
Corteva, Inc. announced on October 1, 2026, the final results of private exchange offers and consent solicitations made by Vylor Inc., a wholly owned subsidiary of Corteva, on beha…
Vylor Inc., a wholly owned subsidiary of Corteva, Inc., has announced the final results of its exchange offers and consent solicitations for outstanding notes issued by its subsidi…
Valion Bio, Inc. (Nasdaq: VBIO) announced on September 30, 2026, the completion of formulation work to develop a novel oral mucosal version of its investigational biologic Entolimo…
Brightline Interactive, Inc. (Nasdaq: BTLN) announced on October 1, 2026, that it has closed a private investment in public equity (PIPE) transaction. The company received gross pr…
Veritone, Inc. has entered into a definitive securities purchase agreement for a registered direct offering. According to the filing dated September 30, 2026, the company agreed to…
USA Rare Earth, Inc. (Nasdaq: USAR) announced on October 1, 2026, the completion of a CEO succession plan. Thras Moraitis, who previously served as President of the company, has as…
Nektar Therapeutics (Nasdaq: NKTR) announced on October 1, 2026, that long-term data from its Phase 2b REZOLVE-AA study in alopecia areata was presented at the European Academy of …
Radnostix Inc. has entered into a definitive asset purchase agreement with NANO Nuclear Energy Inc. and its subsidiary, HALEU Energy Fuel Inc., to divest assets related to a deplet…
Allarity Therapeutics, Inc. (NASDAQ: ALLR) filed a Current Report on Form 8-K dated September 30, 2026, providing an update on its proprietary Drug Response Predictor (DRP) technol…